Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Specimen Handling × Clear all

Sponsor

Conditions

Neoplasm Metastasis 7 Multiple Myeloma 7 Lung Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Neuroblastoma 5 Melanoma 5 Fallopian Tube Neoplasms 5 Burkitt Lymphoma 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Wilms Tumor 3 Triple Negative Breast Neoplasms 3 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Malignant Solid Neoplasm 3 Leukemia, Biphenotypic, Acute 3 Histiocytosis, Langerhans-Cell 3 Hepatoblastoma 3 Hematologic Neoplasms 3 Glioma 3 Ependymoma 3 Central Nervous System Neoplasms 3 Small Cell Lung Carcinoma 2

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡